BACLOFEN
NDC 71225-140, BACLOFEN, suspension, from Slayback Pharma LLC.
- Product NDC
- 71225-140
- Status
- Listed
- Labeler
- Slayback Pharma LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217252
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71225-140 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BACLOFEN5 mg/mL
Pharmacologic classes
GABA A Agonists [MoA]; GABA B Agonists [MoA]; gamma-Aminobutyric Acid-ergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71225-140-01 | 71225014001 | 1 BOTTLE in 1 CARTON (71225-140-01) / 250 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9fad5ffc-afae-4c92-a672-ee636df45bc5
Use it
Look up 71225-140 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71225-140 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71225-140. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.